1,516 Followers on Owler

Autolus

is a biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights

Autolus

is a biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer... Read more
Autolus Chairman & CEO: Christian Itin

Chairman & CEO

Christian Itin

CEO Approval Rating

81/100

2014

PublicNASDAQAUTL

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$10.1M
Employees
647
Funding
$470.7M

News

Conference Presentation
Apr 02, 2025
centralcharts
Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Regulatory
Nov 11, 2024
BioPharma Dive
FDA approves new CAR-T competitor to Gilead's Tecartus

Autolus Competitors

1bluebird bio
2Agenus
3Inovio
4Sangamo
5Kite Pharma
6Intellia
7Immune Design
8CRISPR
9NEC OncoImmunity AS
10AGT
Unlock 17 + competitors

Trending Companies